1. Hui YF, Reitz J (1997) Gemcitabine: a cytidine analogue active against solid tumors. Am J Health Syst Pharm 54:162–170
2. Hilbig A, Oettle H (2008) Gemcitabine in the treatment of metastatic pancreatic cancer. Expert Rev Anticancer Ther 8:511–523
3. Heinemann V, Hertel LV, Grindey GB, Plunkett W (1988) Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-b-arabinofuranosylcytosine. Cancer Res 48:4024–4031
4. Carpenelli G, Bucci G, D’Agnano I, Canese R, Caroli F, Raus L, Brunetti E, Giannarelli E, Podo F, Carapella CM (2006) Gemcitabine treatment of experimental C6 glioma: the effects on cell cycle and apoptotic rate. Anticancer Res 26:3017–3024
5. Cappella P, Tomasoni D, Faretta M, Lupi M, Montalenti F, Viale F, Banzato F, D’Incalci M, Ubezio P (2001) Cell cycle effects of gemcitabine. Int J Cancer 93:401–408